Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Edwards Lifesciences Corp shares valued at $492,258 were sold by Ullem Scott B. on Jun 20 ’24. At $87.51 per share, Ullem Scott B. sold 5,625 shares. The insider’s holdings dropped to 30,561 shares worth approximately $2.85 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Lippis Daniel J. sold 535 shares, netting a total of over 48,150 in proceeds. Following the sale of shares at $90.00 each, the insider now holds 23,513 shares.
Before that, BOBO DONALD E JR had sold 5,000 shares from its account. In a trade valued at $437,696, the CVP,Strategy/Corp Development traded Edwards Lifesciences Corp shares for $87.54 each. Upon closing the transaction, the insider’s holdings decreased to 5,000 shares, worth approximately $4.38 million.
As published in their initiating research note from Goldman on May 30, 2024, Edwards Lifesciences Corp [EW] has been a Buy and the price target has been revised to $107. Analysts at Citigroup upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in late May. As of May 14, 2024, Deutsche Bank has increased its “Hold” rating to a “Buy” for EW. Earlier on March 07, 2024, BofA Securities upgraded its rating. Their new recommendation was “a Buy” for EW stock which previously was a “a Neutral”.
Analyzing EW Stock Performance
During the last five days, there has been a surge of approximately 5.07%. Over the course of the year, Edwards Lifesciences Corp shares have jumped approximately 22.41%. Shares of the company reached a 52-week high of $96.12 on 03/28/24 and a 52-week low of $71.67 on 01/04/24. A 50-day SMA is recorded $87.66, while a 200-day SMA reached $79.97. Nevertheless, trading volume fell to 3.31 million shares from 2.85 million shares the previous day.
Support And Resistance Levels for Edwards Lifesciences Corp (EW)
According to the 24-hour chart, there is a support level at 92.46, which, if violated, would cause prices to drop to 91.58. In the upper region, resistance lies at 93.92. The next price resistance is at 94.50. RSI (Relative Strength Index) is 68.26 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 3.05, which suggests the price will increase in the coming days. Percent R is at 3.29%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
